SciClone to develop and commercialize Theravance’s Vibativ in China
Under the deal, the parties plan to pursue development and commercialization of Vibativ in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP). The company said that additional indications